Andrew Jack

Articles

Cash-to-Doctors Data Reflect Rivalries

Article

Physicians in two specialties receive more money from the pharmaceutical industry than their counterparts in other branches of medicine, according to new data analysis.

Big Pharma, Big Data

Article

Patient groups are hailing a new era of transparency in drug development and clinical trials, but drug companies fear that the publication of so much trial data could damage their business models.